Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Collaborative Groups / Prostate and Urologic Cancers Research Group / Discovery of cancer specific gene fusions (TMPRSS2-ETV1; TMPRSS2:ERG)

Discovery of cancer specific gene fusions (TMPRSS2-ETV1; TMPRSS2:ERG)

Discovery of cancer specific gene fusions (TMPRSS2-ETV1; TMPRSS2:ERG) for the first time in solid epithelial tumors - in prostate cancer and associated with aggressiveness of disease

EDRN Founder Honored

Dr. Sudhir Srivastava was honored with the Distinguished Service Award from the American Pancreatic Association at the group's annual meeting this year, for his outstanding commitment to pancreatology.

Announcement 03/14/2017

Thank you to everyone who made the March 2017 EDRN Steering Committee Meeting a success. The next EDRN Steering Committee Meeting will be on September 12-14, 2018, in Seattle, WA.

Announcement 01/30/2017

Please visit http://www.compass. fhcrc.org/meeting/reg_edrn/edrnsc.aspx for information and to register for the 31st EDRN Steering Committee Meeting in Tempe, AZ, from March 6-9, 2017.